Volpara seeks to raise $A10m from ASX listing

Medtech company reveals financials for first time before IPO that will value it at $A61m. PLUS: Why the ASX over the NZX? With special feature audio.
 

Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login